About Beijing Baike Kangxun Technology
Beijing Baike Kangxun Technology is a company based in Beijing (China) founded in 2006 was acquired by ByteDance in May 2020. Beijing Baike Kangxun Technology has raised $10 million across 2 funding rounds from investors including ByteDance, Lanchi Venture Capital and Cenova. Beijing Baike Kangxun Technology operates in a competitive market with competitors including Roon, theMednet, Curofy, Med Answers and MindRight, among others.
- Headquarter Beijing, China
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Beijing Baike Kangxun Technology
Beijing Baike Kangxun Technology has successfully raised a total of $10M across 2 strategic funding rounds. The most recent funding activity was a Series B round of $10 million completed in August 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Beijing Baike Kangxun Technology
Beijing Baike Kangxun Technology has secured backing from 3 investors, including venture fund and institutional investors. Prominent investors backing the company include ByteDance, Lanchi Venture Capital and Cenova.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Locked | Locked | Locked | |
|
Venture capital fund investing in early-stage tech startups
|
Locked | Locked | Locked | |
|
Short-form video and content discovery platforms are developed.
|
Locked | Locked | Locked |
Investor details for Beijing Baike Kangxun Technology
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Beijing Baike Kangxun Technology
Investment portfolio details for Beijing Baike Kangxun Technology
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Beijing Baike Kangxun Technology
Detailed financials for Beijing Baike Kangxun Technology
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Beijing Baike Kangxun Technology Comparisons
Peer comparison for Beijing Baike Kangxun Technology
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Beijing Baike Kangxun Technology
Beijing Baike Kangxun Technology operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Roon, theMednet, Curofy, Med Answers and MindRight, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
A communication and Q&A platform for patients is provided.
|
|
| Locked | Locked | Locked |
Clinical questions are answered in a physician-only Q&A platform.
|
|
| Locked | Locked | Locked |
Online network for doctors' communication and patient referrals is provided.
|
|
| Locked | Locked | Locked |
Patient to expert medical Q&A platform
|
|
| Locked | Locked | Locked |
Provider of social platform for stress and anxiety management
|
|
| Locked | Locked | Locked |
Membership-based health management services are delivered via an online platform.
|
Detailed competitors of Beijing Baike Kangxun Technology
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Beijing Baike Kangxun Technology
Complete news archive for Beijing Baike Kangxun Technology
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Beijing Baike Kangxun Technology
Beijing Baike Kangxun Technology was founded in 2006 and raised its 1st funding round 12 years after it was founded.
Beijing Baike Kangxun Technology is headquartered in Beijing, China.
Beijing Baike Kangxun Technology is a funded company, having raised a total of $10M across 2 funding rounds to date.
Founded in 2006 in Beijing, China, the company operates in the health technology sector. A platform for doctor-patient interactions is provided, where patients can engage in expert-led QA sessions on various health conditions. Access to doctors covering all medical specialties is facilitated, supporting consultations and information exchange within the Chinese market.
Beijing Baike Kangxun Technology has 3 investors. Key investors include ByteDance, Lanchi Venture Capital, and Cenova.